Impulse News

Impulse Dynamics announced the first implantation of the Optimizer IVs device in Hungary

Impulse Dynamics announced today the first implantation of it Optimizer IVs device in Hungary.  The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF).  The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses. The implantation took place at the Semmelweis University by […]

Read more

Ethics Committee Approvals in Germany for 2 Major Impulse Dynamics Studies

Stuttgart, Germany, July 3rd, 2014 – Impulse Dynamics received Ethical Committee approvals in Germany for its two main randomized controlled clinical studies on CCM™ therapy for heart failure patients, the FIX-HF-5C and the IMPULSE-HF studies. Both studies have Peak VO2 as the primary efficacy end-point to be evaluated over a period of 24 weeks.  The […]

Read more

Impulse Dynamics notes great interest in the new OPTIMIZER™ IVs system at the EUROPACE Congress in Athens

Only a few weeks following the launch of the new OPTIMIZER™ IVs system the company notes great interest in the new CCM system. During the EUROPACE Congress in Athens, a considerable number of inquiries for introduction of the CCM technology and the new OPTIMIZER system were recorded and booked. In the months to come, market introduction […]

Read more

The OPTIMIZER™ IVs device was presented to an international audience during the 2013 Heart Failure Congress in Lisboa

Following the successful introduction of the OPTIMIZER™ IV during the German Cardiac Society’s (DGK’s) Spring Conference in Mannheim, the system was presented to an international audience of professionals during the Heart Failure Congress in Lisboa. An audience of more than 180 people joined the CCM Symposium, eager to learn about the importance of Cardiac Contractility Modulation […]

Read more

The new OPTIMIZER™ IVs device was presented to the German public during the DGK Spring Conference in Mannheim

The new OPTIMIZER™ IVs device was presented during the DGK Spring Conference in Mannheim. Among the specific features of the new device are its minimized size, the low weight and the ergonomic shape which allow for a fast and easy implantation. An optimized algorithm now permits treatment of patients with AV delays of up to 400 […]

Read more

Not All Heart Failure Patients Benefit from CRT

Heart Failure (HF) treatment requires a multifaceted approach. It is usually a combination of nonpharmacologic, pharmacologic, and possibly invasive strategies to limit and reverse the symptoms of heart failure. Treatment of heart failure depends on its cause. The overall goals of treatment are to correct underlying pathology, to relieve symptoms, to prevent a worsening of the […]

Read more

New article published in the Int. J. of Cardiology compares LV reverse remodeling induced by CCM and CRT

ABSTRACT Background: Cardiac contractility modulation (CCM) is a new device-based therapy for advanced systolic heart failure with normal QRS duration and therefore not suitable for cardiac resynchronization therapy (CRT). Left ventricular (LV) reverse remodeling was reported in patients treated with CCM or CRT, however, the extent of response was not compared. Methods: This observational study […]

Read more

Cardiac Contractility Modulation (CCM™) presented at the International Dead Sea Symposium (IDSS 2012)

The 11th International Dead Sea Symposium (IDSS) on Cardiac Arrhythmias and Device Therapy took place in Jerusalem (Israel) on February 26-29, 2012. This event is one of the biggest events to focus on arrhythmology in the Middle East. It is a prestigious platform for professional development and networking in the field of cardiology. This year, […]

Read more

Press Release: Impulse Dynamics Coordinates Cardiac Contractility Modulation (CCM) Certification Training Program

German Cardiologists embrace CCM as therapeutic treatment for heart failure. Berlin, Germany (PRWEB) February 06, 2012 According to Impulse Dynamics, a growing number of cardiologists are employing Cardiac Contractility Modulation (CCM) to bolster their therapeutic armamentarium for patients with chronic heart failure. CCM leads to a long-term increase of cardiac contractility. At a meeting in […]

Read more